Replies to post #357033 on Anavex Life Sciences Corp (AVXL)

[tradeherpete]

There is a learning curve which Anavex is doing well with. Their strong suit is tenaciously sticking to their guns, methodically sorting through the haystacks of neural complexity. It may not be pretty or quick but it is effective.

Investors value time differently than scientists. Time is finite for us, our investment loses value if it doesn’t appreciate at a certain rate and volume. For scientists, they just want to win the game and will not compromise the integrity of the process for investment returns. But only to a point, when the objective becomes irrelevant, the game ends.

But the Avalanche makes a mockery of rate and volume of return so no one’s going anywhere.

There is a condition in semiconductor physics known as "Avalanche". IMO, when A2-73 MOA is validated we will see an avalanche. IMO, the conditions have already been verified in small controlled trials, now we will see the same process applied across multiple CNS indications